Deutsche Apotheker- u. Ärztebank
Deutsche Apotheker- u. Ärztebank: apoBank agrees to comprehensive reorganisation of the Board of Directors
Deutsche Apotheker- u. Ärztebank / Key word(s): Change of Personnel 01.11.2010 19:01 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP - a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- In its meeting today, the Supervisory Board of the Deutsche Apotheker- und Ärztebank e.G. (apoBank) agreed to a far-reaching reorganisation of the Board of Directors. With this, the course has been set for the successful implementation of the immediate action plan, which was also agreed for successful clarification of any potentially unlawful advantages. Stefan Mühr and Claus Verfürth were relieved of their positions on the Board with immediate effect. Dr. Thomas Siekmann's (45) appointment to apoBank's Board of Directors with immediate effect was confirmed in agreement with BaFin. To date, Dr. Siekmann has been the Chief Representative of the apoBank responsible for risk management, among other aspects. The Supervisory Board also appointed Bernd Span (55), subject to the approval of the BaFin and the clarification of a prohibition of competition, with effect from 4th of November 2010 as another member to the bank's Board of Directors. The Board of Directors is to be expanded further in the near future. --------------------------------------------------------------------------- Information and Explaination of the Issuer to this News: Last week, the public prosecutor's office launched an investigation into selected apoBank employees for potentially unlawful advantages. The Board of Directors' spokesman, Herbert Pfennig, immediately initiated an internal investigation to rapidly gain an overview of the scale and causes. First results indicate that certain members of the Board of Directors and employees have acted improperly and are under suspicion of having received unauthorised personal advantages. apoBank currently has no evidence that it has itself suffered financial losses which will impact its planned financial performance. Cassie Kübitz-Whiteley Deutsche Apotheker- und Ärztebank Finanzkommunikation Richard-Oskar-Mattern Straße 6 40547 Düsseldorf E-Mail: cassie.kuebitz-whiteley@apobank.de Tel.: +49(0)211 5998-9809 Fax: +49(0)211 5998-9706 Ines Semisch Deutsche Apotheker- und Ärztebank Finanzkommunikation Richard-Oskar-Mattern-Straße 6 40547 Düsseldorf E-Mail: ines.semisch@apobank.de Tel.: +49(0)211 5998-5308 Fax: +49(0)211 5998-9706 01.11.2010 DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: Deutsche Apotheker- u. Ärztebank Richard-Oskar-Mattern-Str. 6 40547 Düsseldorf Deutschland Phone: +49 211 / 59 98-0 Fax: +49 211 / 59 38 77 E-mail: info@apobank.de Internet: www.apobank.de ISIN: DE0008038803, DE000A0JBMG9, DE000A0JBMQ8, XS0240804558, DE000A0JBMT2, DE000A0JBMU0, XS0244660600, XS0248363045, XS0258779692, XS0263713504, XS0264311316, XS0265611243, XS0271030222, XS0271854795, XS0274180586, XS0280691113, XS0290690428, DE000A0KAP94, DE000A0NKYA0, XS0295191968, XS0301312400, XS0301334800, XS0302167258, DE000A0NKY15, DE000A0NKY64, XS0329990690, DE000A0PM2R2, DE000A0PM2S0, DE000A0PM2Y8, DE000A0PM243, XS0355735423, XS0360003684, DE000A0PM3E8, DE000A0PM3H1, XS0372256650, DE000A0PM3S8, XS0380753813, DE000A0PM3W0, DE000A0XXPE2, DE000A0XXPF9, DE000A0XXPJ1, DE000A0XXPK9, XS0403238214, XS0406697101, DE000A0XXPU8, DE000A0XXPV6, DE000A0XXPW4, XS0409416905, XS0409804159, XS0412045758, XS0413225276, XS0413785733, XS0416547247, XS0417294815, XS0418110218, XS0418386982, XS0418628318, XS0418568589, DE000A0L1FR2, XS0428959547, XS0428960040, XS0429346744 , XS0430599802, XS0431328490, DE000A0L1F18, XS0438740556, XS0441349007, DE000A0L1F83, DE000A1A55X4, DE000A1A55Y2, XS0465245271, XS0465574332, DE000A1A5582, DE000A1A5590, DE000A1A56A0, DE000A1A56B8, XS0478213712, DE000A1A56D4, XS0479407453, XS0479407701, XS0480529089, XS0483205208, DE000A1A56L7, DE000A1A56M5, DE000A1A56N3, XS0495031568, DE000A1C9U34, DE000A1C9U42, DE000A1C9U59, DE000A1C9U67, DE000A1C9U75, XS0499256542, XS0500205504, XS0501832207, XS0505154434, DE000A1DADZ1, DE000A1DAD05, DE000A1DAD13, DE000A1DAD21, DE000A1DAD39, DE000A1DAED6, DE000A1DAEE4, DE000A1DAEF1, DE000A1DAEG9, DE000A1DAEM7, DE000A1DAEN5, DE000A1EWTT2, DE000A1EWTU0, DE000A0ZDF13, DE0001365880, DE0008040924, DE0008040932, DE0008040940, DE0008040957, DE0008040965, DE0008040973, DE0008040981, DE0008040999, WKN: 803880, A0JBMG, A0JBMQ, A0JBMR, A0JBMT, A0JBMU, A0JBM2, A0JBM6, A0JBNL, A0JBNV, A0JBNW, A0KAPB, A0KAPN, A0KAPQ, A0KAPS, A0KAP0, A0KAP8, A0KAP9, A0NKYA, A0NKYF, A0NKYL, A0NKYM, A0NKYP, A0NKY1, A0NKY6, A0PM2N, A0PM2R, A0PM2S, A0PM2Y, A0PM24, A0PM29, A0PM3A, A0PM3E, A0PM3H, A0PM3K, A0PM3S, A0PM3V, A0PM3W, A0XXPE, A0XXPF, A0XXPJ, A0XXPK, A0XXPP, A0XXPS, A0XXPU, A0XXPV, A0XXPW, A0XXP0, A0XXP1, A0L1E8, A0L1E9, A0L1FA, A0L1FD, A0L1FE, A0L1FF, A0L1FG, A0L1FH, A0L1FJ, A0L1FR, A0L1FT, A0L1FU, A0L1FV, A0L1FW, A0L1FX, A0L1F1, A0L1F4, A0L1F5, A0L1F8, A1A55X, A1A55Y, A1A551, A1A553, A1A558, A1A559, A1A56A, A1A56B, A1A56C, A1A56D, A1A56E, A1A56F, A1A56G, A1A56H, A1A56L, A1A56M, A1A56N, A1C9UZ, A1C9U3, A1C9U4, A1C9U5, A1C9U6, A1C9U7, A1DADT, A1DADU, A1DADV, A1DADW, A1DADZ, A1DAD0, A1DAD1, A1DAD2, A1DAD3, A1DAED, A1DAEE, A1DAEF, A1DAEG, A1DAEM, A1DAEN, A1EWTT, A1EWTU, A0ZDF1, 136588, 804092, 804093, 804094, 804095, 804096, 804097, 804098, 804099, Listed: Regulierter Markt in Düsseldorf; Foreign Exchange(s) Luxembourg End of Announcement DGAP News-Service ---------------------------------------------------------------------------
Latest News
Latest Reports
No Reports found
Upcoming Events
No Events found
Webcasts
No Webcasts found